Clinical Trials for Advanced Neuroendocrine Carcinomas Unknown Primary Origin

Find clinical trials for advanced neuroendocrine carcinomas unknown primary origin. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab

NCT ID: NCT07061080

This clinical trial is studying a new treatment called tarlatamab for people with advanced neuroendocrine carcinomas, a rare type of cancer that starts in hormone-producing cells in the digestive s...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Lille, , France, Zaragoza, , Spain +17 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions